![]() |
市場調査レポート
商品コード
1324357
外科手術用縫合糸の2030年までの市場予測:製品タイプ、材料、原材料、コーティング、用途、エンドユーザー、地域別の世界分析Surgical Sutures Market Forecasts to 2030 - Global Analysis By Product Type, Material, Raw Material, Coating, Application, End User and By Geography |
||||||
カスタマイズ可能
|
外科手術用縫合糸の2030年までの市場予測:製品タイプ、材料、原材料、コーティング、用途、エンドユーザー、地域別の世界分析 |
出版日: 2023年08月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の外科手術用縫合糸市場は2023年に48億8,000万米ドルを占め、予測期間中にCAGR 7.8%で成長し、2030年には82億5,000万米ドルに達する見込みです。
外科手術用縫合糸は、手術や怪我の後に傷口を閉じたり、体の組織をつなぎ合わせたりするために使用される医療器具の一部です。通常、糸が付いた針を使って縫合します。どの縫合糸を使うべきかは、傷の特徴や部位によって決まる。医療従事者は、組織をうまくつなぎ合わせるために、糸の引っ張り強度、材質、操作性、伸縮性などを考慮します。
世界保健機関(WHO)によると、2020年2月までに約2,000万~5,000万人が致命的でない怪我に見舞われ、そのうちいくつかは骨折に至り、足関節形成術やその他の骨の手術を連続して受けています。
膝関節置換術、股関節置換術、子宮摘出術、バイパス手術、美容整形手術の増加により、傷をより早く閉じるためのこの器具の使用が増加しています。さらに、高齢者の間で関節置換術、血管形成術、臓器移植などの外科手術の頻度が高まっている結果、外科手術用縫合糸の需要と使用が急速に増加しています。このため、世界中のヘルスケア施設がより高度な機器を求めるようになっています。
研究者は患者の利益のために新技術を開発しており、低侵襲手術の数を増やしています。低侵襲手術は開腹手術よりも低価格で、より良い結果が得られ、入院期間も短くて済みます。これらの要素が低侵襲手術の受容を後押ししており、市場の拡大を制限しています。
外科手術用縫合糸市場は、新興国の人口が近代的な医療施設に対する需要を急速に高めていることに支えられています。最先端ツールや技術の急速な普及が、市場を新たな高みへと押し上げています。潜在的な顧客は、ヘルスケア・システムが傷の縫合に使用する高度な機器に引き寄せられ、市場が長期にわたって多額の利益を生み出すのに役立っています。
有能な外科医の不足と外科手術用縫合糸の高価格が市場の拡大を妨げています。市場拡大に悪影響を及ぼす可能性のあるもうひとつの重大なリスクは、偽物の外科手術用縫合糸の入手可能性と、外科手術用縫合糸の承認と商品化を管理する厳格な規則です。
COVID-19は世界経済に悪影響を与えました。2020年、多くの市場参入企業が衰退に気づいた。パンデミックの間、多くの国の政府はCOVID-19の緊急事態に備えてヘルスケア資源を温存するため、選択的手術を延期しました。これに伴い、多くの市場参入企業や研究機関は、他の慢性疾患に関するプロジェクトを延期せざるを得なくなっています。しかし、最近英国やインドなどで新型のCOVID-19が蔓延していることから、手術を遅らせる傾向がさらに強まり、これらの器具の採用に影響を与えることが予想されます。
縫合糸セグメントは、予測期間中に最大の市場シェアを占めると予測されています。これはヘルスケア分野における莫大な需要の結果です。手頃な価格で一般人でも使用できることから、外科用糸は多くのヘルスケア分野で創傷閉鎖の方法として好まれています。
様々な冠動脈疾患、バイパス手術の必要性を高める不整脈の有病率の増加、および外科手術用縫合糸の使用の増加により、心臓血管外科分野は予測期間中最高のCAGRで成長すると予測されます。最も複雑で危険な外科手術は心臓血管系に関わるため、最適かつ最も適切な縫合糸が必要となります。さらに、心臓疾患患者の増加による心臓血管外科手術の増加も、外科手術用縫合糸の市場需要を増大させています。
北米地域は外科手術用縫合糸市場を独占しており、地元企業や大手企業の存在、他地域に比べて縫合糸のコストが高いこと、有利な償還環境、政府のイニシアチブの拡大、ヘルスケアシステムの高度化などにより、今後もこの分野を支配し続けると予測されます。北米が大きな売上シェアを占める主な要因としては、この地域における国内の高所得と技術進歩が挙げられます。
予測期間中、アジア太平洋地域が最も高い成長を遂げると予測されます。この背景には、手術を受ける可能性が高い高齢化人口や、この分野で満たされていないニーズに対応するためのヘルスケアシステムへの政府支出の増加があります。アジア太平洋地域の主要市場には、中国、インド、日本が含まれます。また、インド、シンガポール、マレーシアといった国々における医療ツーリズムの台頭も、この地域の市場を飛躍的な成長へと押し上げている重要な要因です。
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Surgical Sutures Market is accounted for $4.88 billion in 2023 and is expected to reach $8.25 billion by 2030 growing at a CAGR of 7.8% during the forecast period. A surgical suture is a piece of medical equipment used to close wound edges after surgery or injury and hold body tissues together. Usually, a needle with a thread attached is used to apply it. The characteristics and location of the wound determine which suture should be used. Medical professionals take into account the thread's tensile strength, material, operator friendliness, and elasticity to hold tissues together successfully.
According to the World Health Organization (WHO), till February 2020, around 20-50 million people suffered from non-fatal injuries, of which some resulted in bone fractures, and have consecutively undergone ankle arthroplasty and other bone surgeries.
The use of this device to close wounds more quickly is increasing due to the rise in knee replacements, hip replacements, hysterectomy, bypass surgeries, and cosmetic surgeries. Additionally, the demand for and use of surgical sutures is being increased by the rapidly growing elderly population as a result of the rising frequency of surgical procedures like joint replacement, angioplasty, and organ transplant among elderly patients. This is causing healthcare facilities all over the world to demand more advanced devices.
Researchers are developing new technologies for patients' benefit, which has increased the number of minimally invasive procedures. These procedures are more affordable than open surgeries, offer better results, and require shorter hospital stays. These elements have boosted the acceptance of minimally invasive procedures, which limits the market's expansion.
The market for surgical sutures has been helped by the developing world's population's rapid demand for modern medical facilities. The rapid adoption of cutting-edge tools and technologies by the populace has propelled the market to new heights. Potential customers have been drawn to the sophisticated equipment that the healthcare system uses to suture wounds, which has helped the market generate sizable profits over time.
The market's expansion is hampered by the scarcity of qualified surgeons and the high price of surgical sutures. Another significant risk that could have a negative effect on the market's expansion is the availability of fake surgical sutures and the strict rules governing the approval and commercialization of surgical sutures.
COVID-19 had an adverse impact on the world economy. In 2020, many significant market participants noticed a decline. During the pandemic, the governments of many nations postponed elective surgeries in order to preserve healthcare resources for the COVID-19 emergency. Along with this, the imposition of lockdown forced a number of market participants and research organizations to delay their projects related to other chronic diseases. However, it is anticipated that the recent spread of the new COVID-19 strain in nations like the U.K., India, and others will further the trend of delaying operations and have an impact on the adoption of these devices.
The sutures segment is predicted to hold the largest market share in the estimated timeframe. This is a result of the enormous demand in the healthcare sector. Due to their affordability and ability to be used by the average person, surgical threads have been the preferred method of wound closure in many healthcare sectors.
Due to the increasing prevalence of various coronary artery diseases, arrhythmias, which increase the need for bypass surgeries, and increased use of surgical sutures, the cardiovascular surgery segment is anticipated to grow at the highest CAGR during the projection period. The most complicated and dangerous surgical procedures involve the cardiovascular system, making the best and most appropriate sutures necessary. Additionally, the increased use of cardiovascular surgeries as a result of an increase in patients with heart disorders increases market demand for surgical sutures.
North American region dominated the surgical suture market, and it is predicted to continue dominating the sector due to the presence of local and major players, the high cost of sutures relative to other regions, the favorable reimbursement environment, the expansion of government initiatives, and the sophistication of the healthcare system. The major drivers of North America's significant revenue share include domestically high income and technological advancements in this region.
During the forecast period, Asia Pacific is anticipated to experience the highest growth. This is due to the aging population that is more likely to undergo surgery, as well as an increase in government spending on the healthcare system to address the unmet needs in this area. Major markets in the Asia Pacific region include China, India, and Japan. Another important factor propelling the market in this region toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.
Some of the key players profiled in the Surgical Sutures Market include: Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, CPT Sutures, Deme TECH Corporation, Derma Sciences, Dolphin Sutures, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), Healthium MedTech, Integra Lifesciences, Internacional farmaceutica, Lotus Surgicals, Medtronic Plc , Mellon Medical B.V., Peter Surgical, Smith & Nephew, Stryker Corporation, Surgical Specialties Corporation, Sutcon Sutures, Vital Sutures and Zimmer Biomets.
In July 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) approval for the Vercise™ Neural Navigator 5 Software, which when used as part of the Vercise Genus™ Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.
In August 2022, CONMED Corporation (announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. The transaction is being financed through the Company's existing credit facility.
In March 2022, B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).